GRAL: GRAIL Company Total Revenue

The financial sales dynamics of GRAIL, Inc. (GRAL) reflect market expectations, where the value 0.17 indicates the current revenue figure. Growth is driven by the uniqueness of the Galleri test and the low demand elasticity for cancer diagnostics. However, geopolitical tensions are limiting access to global biodata. The business is currently scaling operations and seeking recognition of its tests by insurance companies.

GRAIL, Inc. (GRAL) Revenue and Sales Volume: for the period 06/29/2024 - 11/13/2026

Comprehensive metric breakdowns and analytics for GRAIL (GRAL)

- stock quotes and analyst forecast:

Price Chart GRAIL Bio|GRAL - Consensus Target

- market capitalization information:

Market Value GRAIL, Inc.|GRAL - Total Company Value

- book value of equity indicators:

Net Assets per Share GRAIL|GRAL - Book Capitalization|Market Capitalization to Book Value grail.com|GRAL - Aggregate Company Assets

- company liabilities and liquidity data:

- earnings and market multiples details:

GRAL - Company Net Income|Expected Profit GRAIL, Inc.|GRAL - Price to Earnings Ratio|Future Price to Earnings Multiple grail.com|GRAL - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio GRAIL, Inc.|GRAL - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months GRAIL|GRAL - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months grail.com|GRAL - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year GRAIL, Inc.

- company sales and revenue statistics:

GRAL - Revenue and Sales Volume|Company Sales Forecast GRAIL Bio|GRAL - Price-to-Revenue Ratio|Forward Price to Sales GRAIL, Inc.

Comprehensive company analysis:GRAIL Bio - GRAL

GRAIL, Inc. is commercializing the innovative Galleri AI-powered multi-cancer early detection test. This metric captures the aggregate cash inflow from the delivery of these services, reflecting the business's daily revenue. Stable dynamics confirm the scaling of the technology and the market adoption of the product. Analyzing the company's operational sales allows for the timely identification of demand stagnation or the risk of losses. The operational sales trend determines the asset's real fundamental value.

Key competitors